Bowman Birk Inhibitors (BBI) in interception of inflammation and malignant transformation of OPMDs

The most implausible aspect of cancer therapy is to develop drugs to seize the progression of initial stages of carcinogenesis, preferably termed as known as chemopreventive agents [1]. Though studies support oral premalignancy to be an ideal study model for chemopreventive agents [2], curbing oral cancer by concentrating on dietary chemoprevention agents are yet to be developed with time [3]. The example study being of 13-cis-retinoic acid, which was ratified successful till cessation of therapy reverted the premalignancy, making it a gross disappointment [2].

http://ift.tt/2nMPGOB